Skip to main content

Table 2 Pretrial and trial data by group and period

From: A multi-faceted intervention including antenatal corticosteroids to reduce neonatal mortality associated with preterm birth: a case study from the Guatemalan Western Highlands

Characteristic

Pre trial

Trial period, N (Rate/1000)

Intervention

Control

Intervention

Control

RR (95 % CI), p-value

Babies

2,053

2,321

3,800

3,978

--

 Live births

2,007 (97.8)

2,271 (97.8)

3,725 (98.0)

3,905 (98.2)

--

 <5th percentile live births (% of live births)

77 (3.8)

105 (4.6)

197 (5.3)

166 (4.3)

--

Neonatal death 28 daysa

     

 Overall

59 (29.7)

68 (29.9)

81 (21.7)

102 (26.1)

0.88 (0.73, 1.06), p = 0.1875

 <5th percentile

22 (285.7)

23 (219.0)

36 (182.7)

39 (234.9)

0.74 (0.68, 0.81), p = <.0001

  1. aThe denominator for neonatal mortality is all live births. Of the 2,007 live births in the intervention group during the pre-trial period 21 missing 28-day status are excluded from the denominator